CTBP1 and pancreatic neoplasm: It has been shown that the binding of NNK to the β-ARs induce pancreatic cancer cell proliferation by activating the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) pathways in pancreatic cancer cells [22].